Home COVID-19 Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay

Wednesday, June 17, 2020

Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay

COVID-19
Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay submitted by /u/GallantIce
[link] [comments]

Artikel Terkait

Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay
4/ 5
Oleh
Komentar

Berlangganan

Suka dengan artikel di atas? Silakan berlangganan gratis via email


EmoticonEmoticon